Epidemiology and Infection, Vol. 140, No. 8 (AUGUST 2012), pp. 1343-1355 (13 pages) Global coverage of infant Haemophilus influenzae type b (Hib) vaccination has increased considerably during the past ...
Experimental data from FAP-Exd (AVA6103) demonstrates a more favorable profile compared to the marketed Antibody Drug Conjugate (ADC) ...
TORONTO--(BUSINESS WIRE)--AB SCIEX and Dalton Pharma Services (Dalton) announced today a research collaboration to develop Antibody-Drug Conjugate (ADC) analysis capabilities. This will include ...
AB SCIEX and Dalton Pharma Services announced that they are joining forces on R&D for antibody-drug conjugate analysis capabilities. "A key challenge for developing successful antibody-drug conjugate ...
The report identifies key opportunities in Antibody-Drug Conjugates through insights on past trends, drug pipelines, and leading companies. It serves investors, new entrants, and pharma firms looking ...